FDA inspection
AstraZeneca AB: FDA inspection ending May 29, 2012
FDA inspection 853188 · No Action Indicated (NAI) · Sodertalje
Key facts
| Inspection ID | 853188 |
|---|---|
| Firm | AstraZeneca AB |
| FEI number | 3002806411 |
| Address | Forskargatan 18 Se-151 36 Se-151 36 |
| City | Sodertalje |
| Country | Sweden |
| Fiscal year | 2012 |
| Inspection end date | May 29, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data